Known as mandatory product listing (MPL) for dietary supplements, supporters claim it's a way for the FDA to know what products are on the market and what ingredients they include

Opponents suggest the move, which is redundant and burdensome for small supplement companies, could ultimately give the FDA more power to ban supplements from the market

MPL could pave the way for the FDA to gain premarket approval power — changing access to supplements as we know it

Multinational companies like Bayer, Nestle, Unilever, Proctor & Gamble and Clorox have also been buying up supplement companies at a frenzied pace. In 2018, there were 83 such transactions; this rose to 137 in 2021